Diarrhea-predominant irritable bowel syndrome (IBS-D) is a multifactorial disorder involving gut-brain axis dysregulation, altered barrier integrity, microbial imbalance, and stress-related mechanisms, with limited nutritional strategies targeting these pathways. Tannin-rich extracts may exert barrier-protective, microbiota-modulating, and stress-related effects. In a prospective before-after pilot study (NCT05207618), 28 adults with IBS‑D completed a 60‑day tannin-based supplementation (480 mg/day). Outcomes included IBS Severity Scoring System (IBS-SSS), bowel habits, somatization, perceived stress, serum zonulin, faecal short-chain fatty acids, and hydrogen breath test. Linear mixed models assessed changes over time. IBS-SSS decreased by an estimated mean of 70 points (95% CI: 34-107; p < 0.0001); stool consistency improved by 1.38 (95% CI: 0.72 to 2.05; p < 0.0001), and bowel movements/day decreased by 0.84 (95% CI: 0.08 to 1.71; P = 0.028). Somatization and stress scores declined significantly (both P ≤ 0.003). Zonulin dropped (P < 0.0001), butyrate increased (p = 0.001), and propionate decreased (p = 0.017). Hydrogen-positive subjects at baseline (3/28) were all negative at 60 days. No adverse events occurred. This pilot suggests a tannin-based phytocomplex may improve gastrointestinal and psychological symptoms in IBS-D, with biomarker changes indicating enhanced barrier function and microbial metabolism. Larger trials are warranted.
Keywords: Clinical Pilot study, Gut‐Brain Axis, Irritable Bowel Syndrome, Short Chain Fatty Acids, Tannins
Molecular nutrition & food research
Journal Article
English
42003449
Guideline Central and select third party use “cookies” on this website to enhance the user experience.
This technology helps us gather statistical and analytical information to optimize the relevant content for you.
The user also has the option to opt-out which may have an effect on the browsing experience.